< 1 minute read
Sep. 17, 2021

GSK2818713: an HCV NS5A replication complex inhibitor

GSK2818713

broad geno. HCV NS5A repl. complex inhibitor low Cl and orally available in higher species from rational design from known ligand J. Med. Chem., Apr. 23, 2020 GlaxoSmithKline, Research Triange Park, NC

drughunter.com
Drug Hunter Team

GSK2818713 is an HCV NS5A replication complex inhibitor with an interesting biphenylene linker. The crowded, hotly competitive NS5A space has led to a lot of creative chemical scaffolds including this one.

Loading...

twitterlinkedinemail

Other molecules you may be interested in